David Ovalle

Author's posts

Federal health agency recommends easing marijuana restrictions

The Department of Health and Human Services has recommended that marijuana be reclassified as a lower-risk Schedule III controlled substance.

Opioid-maker Mallinckrodt’s bankruptcy will cut nearly $1 billion from settlement

Drug maker Mallinckrodt, on the hook for more than $1 billion in opioid settlement payments, plans to file for bankruptcy for a second time. The move imperils the $1.7 billion opioid settlement struck last year.

Supreme Court pauses Purdue Pharma settlement plan worth billions

The court granted the Justice Department’s request to temporarily block the plan, which would shield Sackler family members from future lawsuits.

Patients grapple with side effects of popular weight-loss drugs

The medications help people lose significant weight but can cause nausea and other complications.

FDA approves first oral drug for postpartum depression

It’s estimated 1 in 7 women suffer from the condition after giving birth.

Marijuana addiction is real. Those struggling often face skepticism.

Dozens of states have legalized recreational sales, with experts saying most people don’t experience serious health woes. But some do.

Vaccine politics may be to blame for GOP excess deaths, study finds

Yale researchers found that registered Republicans in Ohio and Florida had a higher rate of excess deaths than Democrats.

Rising number of overdose deaths involve mix of opioids with cocaine, meth

A federal analysis shows that between 2011 and 2021, the rate of overdose deaths involving opioids and cocaine nearly quintupled.

U.S. charges Chinese companies over fentanyl chemicals, two arrested

The target “blatantly advertised” chemicals and targeted cartel clients with claims of “Mexico hot sale” and “100% stealth shipping,” federal officials say.

White House meets with drug firms on cost of overdose-reversal drugs

One drugmaker said it was committed to expanding access to naloxone for “millions of Americans” and “maintaining affordability.”